Skip to content

Contact


MMRGlobal, Inc.
4401 Wilshire Blvd.
2nd Floor
Los Angeles, CA 90010
1-888-808-4667
Email: info@mmrmail.com


Transfer Agent: Computershare

Mailing Addresses:

Shareholder correspondence should be mailed to:
Computershare
P.O. Box 43006
Providence, RI 02940-3006


Overnight correspondence should be mailed to:
Computershare
250 Royall Street
Canton, MA 02021


Shareholder Website:
www.computershare.com/investor

Shareholder Online Inquiries:
https://www-us.computershare.com/investor/Contact

Press Releases


Printer Friendly Version View printer-friendly version
<< Back
MyMedicalRecords Launches Television Advertising for Interoperable Personal Health Record on Sale at National Retailers

LOS ANGELES, CA -- (Marketwired) -- 10/13/14 -- MMRGlobal, Inc. (OTCQB: MMRF) ("MMR") today announced that the Company is launching a national television advertising campaign for its MyMedicalRecords Personal Health Record ("PHR") through Associated Television International (www.associatedtelevision.com). Consumers are becoming more aware of the importance of having a Personal Health Record so that in the event of a medical emergency or disaster, copies of their actual medical records, important documents and travel history are securely available from any Internet-connected device. Two nationally syndicated television commercials, including retailer tags, can also be seen at http://youtu.be/0vlP-V4sjAg and http://youtu.be/MF5P2tOoSE4. The commercials focus on the value of being prepared for any medical emergency and the benefits of having a PHR as part of a family's disaster preparedness plan.

According to Robert H. Lorsch, MMRGlobal CEO, "At this time, when hospitals rely on diagnostic decisions by computer through an Electronic Medical Records ("EMR") system, it's more important than ever for the patient to be in control of their care. EMRs are being installed in hospitals and medical offices nationwide. Many healthcare professionals rely on them for diagnostic decisions, often removing the human care element by looking at a screen instead of the patient. These systems have cost taxpayers more than 28 billion dollars through reimbursements mandated under the HITECH Act. The impact of this shift in the care of a patient is scary. Even after Ebola patient zero told an emergency room intake person that he had just returned from Liberia, the EMR system on site sent the patient home to be treated for flu. Had the patient had a PHR that the emergency room could have looked at, doctors would have immediately seen that he had traveled from Africa, and the outcome might have been very different." (http://www.nationalreview.com/article/389817/ebola-electronic-medical-records-and-epic-systems-michelle-malkin)

The MyMedicalRecords Personal Health Record, which includes a MyEsafeDepositBox inside that provides an online site to securely store legal, financial, insurance and other important documents in addition to medical and personal health information, covers up to 10 family members, including pets. A new easy-to-use "Personal Health Record Kit" is also available in both 6-month and 12-month packages. The 12-month package comes with an offer of free concierge service to help collect a family's medical records and load them into an account. Information about the free concierge service can be found at Walgreens.com. By clicking on the button that says "Take a Product Tour," consumers can choose four videos that explain the features and benefits of having a MyMedicalRecords account and the importance of being in control of their family's personal health information. Information about MyMedicalRecords can also be found at www.mmrvideos.com.

MyMedicalRecords, Inc. is a practicing entity and a leading provider of secure and easy-to-use Personal Health Records through its MyMedicalRecords PHR, and MMRPro document management and imaging systems for healthcare professionals. MMR currently has 13 issued U.S. health IT patents including U.S. Patent Nos. 8,301,466; 8,352,287; 8,352,288; 8,121,855; 8,117,646; 8,117,045; 8,321,240; 8,498,883; 8,626,532, 8,645,161; 8,725,537; 8,768,725 and 8,775,212, as well as additional applications and continuation applications involving inventions pertaining to Personal Health Records, Patient Portals and other Electronic Health Record systems. The most recently issued patent, U.S. Patent No. 8,775,212, represents MMR's first Clinical Trials patent and includes 18 claims directed to methods and systems that provide for self-reporting being used to create Electronic Health Records for purposes including Clinical Trials. In addition to the U.S., MMR currently has patents issued, pending and/or applied for in 11 other countries or regional authorities including Australia, Singapore, New Zealand, Mexico, Japan, Canada, Hong Kong, China, South Korea, Israel and Europe.

About MMRGlobal

MMRGlobal, Inc., through its wholly-owned operating subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use online Personal Health Records ("PHRs") and electronic safe deposit box storage solutions, serving consumers, healthcare professionals, employers, insurance companies, financial institutions, retail pharmacies, and professional organizations and affinity groups. The MyMedicalRecords PHR enables individuals and families to access their medical records and other important documents, such as birth certificates, passports, insurance policies and wills, anytime from anywhere using the Internet. MyMedicalRecords is built on proprietary, patented technologies to allow documents, images and voicemail messages to be transmitted and stored in the system using a variety of methods, including fax, phone, or file upload without relying on any specific electronic medical record platform to populate a user's account. MMR's professional offering, MMRPro, is designed to give physicians' offices an easy and cost-effective solution to digitizing paper-based medical records and sharing them with patients through an integrated patient portal. Through its merger with Favrille, Inc. in January 2009, MMR acquired intellectual property biotech assets that include anti-CD20 antibodies and data and samples from its FavId™/Specifid™ vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's lymphoma. To learn more about MMRGlobal, Inc. visit www.mmrglobal.com. View demos and video tutorials of MMR's products and services at www.mmrtheater.com. Follow us on Facebook.com/MMRGlobal and Twitter.com/mmrglobal.

Forward-Looking Statements
All statements in this release that are not strictly historical facts are "forward-looking statements." Such forward-looking statements are based on MMR's current assumptions, beliefs and expectations, and involve risks, uncertainties and other factors that may cause MMR's actual results to be materially different from any results expressed or implied by such forward-looking statements. Some can be identified by the use of words such as "expect," "plan," "possibility," "offer," "if," "negotiate," "when," "believe," "will," "estimate," "continue," and similar expressions. Actual outcomes and results of operations and the timing of selected events may differ materially from the results predicted, and any reported results should not be considered as an indication of future performance. Such statements are necessarily based on assumptions and estimates and are subject to various risks and uncertainties, including those relating to the possible invalidity of the underlying assumptions and estimates and possible changes or developments in economic, business, industry, market, legal and regulatory circumstances and conditions and actions taken or omitted to be taken by third parties, including customers, suppliers, business partners, potential licensees, competitors and legislative, judicial and other governmental authorities and officials. Factors that could cause or contribute to such differences include, but are not limited to: unexpected outcomes with respect to intellectual property enforcement actions, claims of intellectual property infringement and general intellectual property litigation; our ability to maintain, develop, license, and protect our patent portfolio for both the MMR's health IT and biotechnology intellectual property assets in the U.S. and internationally; the timing of milestone payments in connection with licensing our intellectual property; our ability to establish and maintain strategic relationships; changes in our relationships with our licensees; the risk MMR's products are not adopted or viewed favorably by the healthcare community and consumer retail market; business prospects, results of operations or financial condition; risks related to the current uncertainty and instability in financial and lending markets, including global economic uncertainties; advertising and commercial clearances; the timing and volume of sales and installations; the length of sales cycles and the installation process; the market's acceptance of new product and service introductions; competitive product offerings and promotions; changes in government laws and regulations and future changes in tax legislation and initiatives in the healthcare industry; undetected errors in our products; the possibility of interruption at our data centers; risks related to third party vendors; risks related to obtaining and integrating third-party licensed technology; risks related to a security breach by third parties; risks associated with recruitment and retention of key personnel; other litigation matters; uncertainties associated with doing business internationally across borders and territories; and additional risks discussed in MMR's public filings with the Securities and Exchange Commission, including the risks discussed in the "Risk Factors" section in MMR's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Copies of these reports can be found on MMR's website (www.mmrglobal.com) under the heading "Investor Relations." MMR is providing this information as of the date of this release and, except as required by applicable law, does not undertake any obligation to update any forward-looking statements contained in this release as a result of new information, future events or otherwise.

CONTACT:

Michael Selsman
Public Communications Co.
ms@publiccommunications.biz
(310) 922-7033

Source: MMRGlobal, Inc.